Rhenman & Partners Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-150,000	Closed	-$1.5M	–	95
2021 Q3	$1.5M	Buy	150,000 +50,000	+50%	+$499K	0.11%	89
2021 Q2	$3.09M	Buy	+100,000	New	+$3.09M	0.21%	87